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Abstract: Recent reports from Europe and the USA described Seoul orthohantavirus infection in
pet rats and their breeders/owners, suggesting the potential emergence of a “new” public health
problem. Wild and laboratory rat-induced Seoul infections have, however, been described since
the early eighties, due to the omnipresence of the rodent reservoir, the brown rat Rattus norvegicus.
Recent studies showed no fundamental differences between the pathogenicity and phylogeny of pet
rat-induced Seoul orthohantaviruses and their formerly described wild or laboratory rat counterparts.
The paucity of diagnosed Seoul virus-induced disease in the West is in striking contrast to the
thousands of cases recorded since the 1980s in the Far East, particularly in China. This review of
four continents (Asia, Europe, America, and Africa) puts this “emerging infection” into a historical
perspective, concluding there is an urgent need for greater medical awareness of Seoul virus-induced
human pathology in many parts of the world. Given the mostly milder and atypical clinical
presentation, sometimes even with preserved normal kidney function, the importance of simple but
repeated urine examination is stressed, since initial but transient proteinuria and microhematuria are
rarely lacking.
Keywords: hantavirus; Seoul virus (SEOV); brown rat; wild rat; laboratory rat; pet rat; hemorrhagic
fever with renal syndrome (HFRS); acute kidney injury (AKI); hantavirus cardio-pulmonary syndrome
(HCPS); hantavirus disease
Highlights: Rat (wild, laboratory, or pet)-induced hantavirus disease is one of the oldest known
forms of hantavirus infection, and the only one with a global spread, due to the omnipresence
of its rodent reservoir. The causative agent, Seoul orthohantavirus (SEOV), is moreover the only
orthohantavirus species with multiple isolations in four continents, mostly made in the pioneer early
1980s. Paradoxically, SEOV-induced hantavirus disease is apparently still often missed or misdiagnosed,
perhaps due to its often mild and atypical clinical presentation [1].
1. Introduction
Hantaviruses are the cause of “emerging” rodent-borne viral hemorrhagic fever (VHF), known to
western medicine since the early 1980s. They are mostly linked to a unique species of asymptomatic
rodent reservoirs with a distinct, but geographically well-limited biotope, shedding infectious viral
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particles in their excreta. Transmission to humans occurs mostly via the inhalation of these particles,
causing multiple forms of organ pathology, via a transient so-called “pro-inflammatory cytokine
storm”. Old World hantaviruses mainly target the human kidney, causing “hemorrhagic fever with
renal syndrome” (HFRS), whereas New World hantaviruses, discovered since 1993, mainly target the
lung, causing “hantavirus cardio-pulmonary syndrome” (HCPS), but many clinical overlaps between
HFRS and HCPS are increasingly reported. Rather paradoxically, the brown rat (Rattus norvegicus),
being the only global hantavirus rodent reservoir, clearly also present in the New World, deserved
little scientific interest in past decades, thus maintaining an original misconception that HFRS was a
disease representative for the Old World, and HCPS for the New World [1].
The recent discovery, both in Europe and the USA, that SEOV-infected pet rats could also cause
HFRS in their owners or breeders resulted in a sudden resurge of the research into rat-transmitted
hantaviral disease.
2. Prelude
In December 2016, an owner of a Wisconsin (USA) in-home rattery was hospitalized with fever,
leukopenia, elevated transaminases and proteinuria. Although no typical acute kidney injury (AKI) was
reported, the patient was serologically diagnosed with an acute Seoul orthohantavirus (SEOV) infection.
However, mild and atypical clinical presentations are a constant feature of SEOV-induced HFRS forms,
as repeatedly shown hereunder [1]. A family member later developed similar symptoms, but was not
hospitalized [2]. In late December, 2016, a report of mild AKI followed in an 18-year-old female from
Tennessee (USA) (hematuria and peak serum creatinine level of 1.27 mg/dL). In April 2017, a second
case was reported in her 38-year old mother who was hospitalized for gastro-intestinal symptoms with
dyspnea and even milder AKI (peak serum creatinine 1.13 mg/dL, with mild thrombocytopenia of
143,000/µL). In the latter case, SEOV RNA was detected by reverse transcription-polymerase chain
reaction (RT-PCR). Both cases appeared to have been caused by pet rat-transmitted SEOV, and both
recovered without treatment or complications [3,4]. The USA Center of Disease Control and Prevention
(CDC) launched a nationwide investigation, identifying 31 rat-breeding facilities with human and/or
rat SEOV infection in 11 USA states, six of which exchanged rats with Canadian ratteries. A total of
24/183 (13.1%) US or Canadian residents associated with these facilities were found to be serologically
SEOV-positive, resulting in three hospitalizations in the USA. No AKI was mentioned, and spontaneous
recovery occurred, whereas no serious illness was reported from Canada [2]. Similar cases, with or
without AKI, and all induced by apparently healthy pet rats, were described in the UK [5,6] and
in France [7]. Recently, increasing reports of wild and pet rat-associated SEOV-induced hantavirus
disease in the USA and Europe reflected a renewed awareness of the disease outside of Asia, breaking
years of misconceptions about the true distribution and clinical aspects of hantavirus diseases.
The decades-long assumption that HFRS was limited to the Old World, and HCPS restricted to the
Americas, ignored the remarkable global progress made by pioneer hantavirologists in the early 1980s.
Rat-transmitted hantavirus or SEOV is the second oldest isolated hantavirus (1980) [8], the first isolated
hantaviral pathogen in the USA (1984) [9], and the most widely distributed hantaviral pathogen, due
to the omnipresence of its reservoir and vector, the brown or Norway rat (Rattus norvegicus). Before the
unexpected 1993 discovery of two other autochthonous American hantaviral pathogens, Sin Nombre
orthohantavirus (SNV), followed by Andes orthohantavirus (ANDV), early hantavirology in the USA
focused primarily on SEOV and its possible impact on human health. A 1994 compilation of the
then existing world literature confirmed hantavirus-antibodies, -antigen, and -virus isolation in two
different classes of animals (mammals and birds), eight different orders, 24 different families and a
total of 164 different species, mostly small mammals. Of these, the rat was by far the species yielding
most positive results, i.e., in 34 different countries for the brown rat, 20 countries for the roof rat (Rattus
rattus), 19 countries for non-specified Rattus species (which may include pet rats), and in 13 countries
for laboratory rats [10]. To date, SEOV is still the only hantavirus with multiple isolations in four
different continents (Asia, Europe, America, and Africa) (see hereunder), a unique accomplishment by
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different hantavirus researchers beginning 1980s, considering the inherent difficulties associated with
isolating hantaviruses. So far, the limited attempts for pet rat isolations of SEOV, both from rats and
humans, have been unsuccessful.
In the Far East, and particularly in China, extensive annual mixed epidemics, caused by prototype
Hantaan orthohantavirus (HTNV) and/or SEOV, resulted in tens of thousands of human infections
yearly. In contrast, although American authors once called “the SEOV prevalence in [wild] rats in
many United States cities among the highest recorded globally” [11–13], there has been little noticeable
impact over the subsequent three decades on human morbidity and/or mortality in North America.
Similarly, North-American pet rats have had only limited reported consequences for public health
so far [2]. The novel notion, however, that even fancy pet rats might infect their owners or breeders
with a zoonotic agent (SEOV), previously thought to be limited to wild rats, has the potential to
dramatically change our insights about the global importance of rat-transmitted HFRS, since pet rat
trade is international, and likely also to be found beyond Europe and North America [13].
Additionally, outbreaks among laboratory workers in Asia, Russia, and Europe in the 1960s and
1970s, associated with SEOV-infected laboratory rats [13], played a pivotal role in understanding the
“new” human illness, later called HFRS after a World Health Organization (WHO) meeting, during
which the clinical characteristics of HFRS were, be it succinctly, described [14]. This early clinical and
epidemiological knowledge was overshadowed a decade later with the discovery of a new and often
lethal disease caused by SNV or ANDV, and called HCPS [15].
In Section 3, “Overview”, we discuss the recorded history of SEOV [10,16–19] and SEOV-induced
human infections in four continents, followed by the current status of pet and domesticated rat
SEOV infections.
3. Overview of Chronological SEOV Findings by Continent
3.1. SEOV in South-East Asia and in the Far East (Figure 1, Asia)
Clinical and later serological recognition of a viral malady, unkown to the West, but caused by the
omnipresent an often domestical brown rat, was pivotal for the development of hantavirology in the
early 1980s, this time outside of the Far East, Korea being a frontrunner, but rapidly followed by Japan,
and particularly by China, where the extensive public health problem caused by recurrent waves of
SEOV-HFRS up to today, is still underestimated in Western medical literature (Figure 1).
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Figure 1. The map does not aspire to completeness and refers only to data given in the text. The first
SEOV isolation occurred in 1980 in S. Korea [8], followed in 1982 by China [20], and in 1983 by
Japan [21]. Whereas China suffered mixed HTNV-SEOV epidemics, involving thousands of cases,
each year, laboratory rat-transmitted SEOV outbreaks were an extensive and recurrent problem in
several Japanese medical institutions, during the 1970–1980s (see text). The question mark in Sulawesi,
Indonesia, refers to a SEOV infection in a German tourist [22], which may, however, have occurred
after his return home (see text under “Germany).
3.1.1. SEOV in Korea and South-East Asia
SEOV in Korea
The first isolation of HTNV in 1976 [23] was from the Korean striped field mouse (Apodemus
agrarius coreae). HTNV became the prototype of all ensuing hantaviruses, but was rapidly followed
by the isolation of another hantavirus in 1980, retrieved from an urban brown rat, captured in an
apartment building in Seoul, South Korea [8]. It was called SEOV 80-39, after local urban HFRS
outbreaks involving hundreds of cases [8]. Originally, a clear distinction between prototype HTNV
76-118 and prototype SEOV 80-39 was not made, since both pathogens seemed initially to induce a
similar HFRS clinical picture in humans, and because both strains heavily cross-reacted serologically,
i.e., in the indirect immunofluorescent antibody assay (IFA), commonly used then. Consequently,
early SEOV findings in rats and humans were often labelled as “HTNV-like”. Prototype HTNV
76-118 continued to be used for many years as an IFA antigen for screening human populations
and/or HFRS-like diagnosis worldwide, including regions where no human hantavirus infections
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had previously been noted. IFA cross-reactions, however, helped pioneer diagnosis in Russian and
European HFRS cases, caused in fact by arvicolid orthohantavirus Puumala (PUUV), but it became
clear that “HTNV-like” IFA results in some regions were often found in ill, or even asymptomatic,
individuals with a history of overt exposure to wild or laboratory rats. In retrospect, some of these
early findings may have been due to SEOV infections.
Interest in SEOV gained momentum after a series of outbreaks occurred in several Far-East research
laboratories, all causing a mild HFRS-like illness, and occurring among doctors and technicians working
with Fisher or Wistar rats. In South Korea, nine laboratory staff and two casual visitors developed
HFRS between 1971 and 1979 [24]. Since prototype HTNV was only isolated in 1976, it seems likely
that laboratory rat-induced SEOV, rather than A. agrarius-borne HTNV, may have been the cause of
these early laboratory outbreaks.
The propagation of HTNV, formerly called “Korean hemorrhagic fever” virus (KHFV), in Fisher
or Wistar rats and use of their lung tissue as an IFA antigen was published in 1981 as a convenient
way to make the then novel diagnostic IFA technique globally available [25]. Previously, the lungs
of A. agrarius were used as a source of IFA antigen and availability was restricted primarily to the
Far East. At that pioneer time, laboratory rats were considered “an animal model free of wild rodent
viruses” [25]. However, two SEOV strains were isolated in 1984 from Korean laboratory rats, KSNUSD
84/30 and 84/34 ([26], p.807). Moreover, unapparent aerosol transmission of “HTNV-like” viruses to
laboratory rats from other infected cage mates was shown to be a distinct possibility [27]. Shortly after
IFA, another screening technique was developed, and called plaque reduction neutralization tests
(PRNT), being a more cumbersome serological test, necessitating live virus cultures, but less prone
than IFA to cross-reactions. Still later, a much more reliable molecular genotyping technique was being
employed, called reverse transcription-polymerase chain reaction (RT-PCR), now considered as the
gold standard. In a first retrospective 1994 study, PRNT-confirmed SEOV infection appeared to be the
cause of 25% of HFRS cases in Korea, and showed a milder renal and hemorrhagic involvement than
in HTNV-caused cases [28].
SEOV in South-East Asia
From the 1980s on, it became clear that HFRS in non-endemic areas might be milder, and with
“atypical” symptoms involving the liver much more than the kidney. In South-East Asian countries,
this often led to missed or incorrect (“viral hepatitis”) clinical diagnoses, instead of HFRS. All these
countries had, and still have, the wild rat as the most important reservoir for pathogenic hantaviruses.
In Malaysia, a “HFRS case involving the liver” was reported in 1987 [29], followed by “hepatitis-like
HFRS” outbreaks involving infected wild and laboratory rat colonies [30]. In Singapore in 1988, 44%
(143/329) of laboratory rats were found IFA-seropositive to HTNV, but none had hantaviral antigen
in lung tissues. Two of 74 laboratory personnel were also seropositive, but neither had a history of
HFRS-like clinical illness [31]. In a subsequent Singapore study, R. norvegicus was the predominant
species captured, with the highest “HTNV-like” seropositivity (36/113 or 32%), resulting in the isolation
of R36, a SEOV strain. Two Singapore patients had marked liver dysfunction, but only mild renal
involvement, confirming the concept of a “new hepatitis-like hantaviral disease” [32]. Much later,
RT-PCR and sequencing of samples from different captured rat species in Singapore resulted in the
characterization of SEOV strains Singapore RN 41 and 46 from the brown rat, and strain Jurong TJK/06
from the Oriental house rat, R. tanezumi [33]. The latter strain, with Serang virus from the Oriental
house rat in Indonesia, Anjozorobe virus from the roof rat in Madagascar, and Mayotte virus from the
roof rat in Mayotte Island are variants of the species Thailand orthohantavirus (THAIV), formerly (1985)
isolated from greater bandicoot rats (Bandicota indica) in Thailand [34–37]. Already in 1994, it was clear
that murid THAIV showed marked serological cross-reactions with SEOV strains [38]. Brown rats
with Singapore RN 41 and/or 46 were found all over the island, suggesting they were not a recent
introduction. Nevertheless, the authors noted the striking local paucity of typical HFRS, with only one
sero-confirmed case in Singapore for the last 15 years [33].
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In 1985, four SEOV isolations were made from urban rats in Hong Kong (strains R 85/14, 19,
35, and 40) [39]. Rat-associated hantavirus infection in both rat and human sera in Hong Kong was
subsequently confirmed by IFA and PRNT [40], and two HFRS cases were serologically confirmed ([26],
pp. 804 and 807). In rural and urban areas of Cambodia, anti-HTNV IgG was found in 6.4% (13/203) of
roof rats, 20.9% (39/187) of brown rats, and none in 183 Pacific rats (R. exulans) or in 75 greater bandicoot
rats. In 87% of seropositive rodents, RT-PCR confirmed the presence of SEOV RNA from brown rats
and of THAIV from the roof rat, [41,42]. To our knowledge, however, no HFRS case has been reported
from Cambodia. SEOV was also detected from wild brown rats in Vietnam [43–47] and four HFRS
cases were attributed to SEOV using serological tests [43,44]. Finally, among 115 cases hospitalized in
Thailand for fever of unknown origin (FUO), one appeared IgM- and IgG-positive by HTNV ELISA
and IgG-positive by HTNV IFA, showing acute encephalitis, thrombocytopenia, coagulation anomalies,
and elevated liver transaminases, now commonly called “transaminitis” [48]. From the same country,
1/260 leptospirosis-suspected patients was found seronegative for leptospirosis, but had high-titers by
HTNV IFA and by PRNT for THAIV, suggesting a pathogenic role in Indochina for THAIV [49].
3.1.2. SEOV in the Far East
SEOV in Japan
Of interest, all HFRS cases hitherto reported from Japan seem to have been exclusively
rat-transmitted cases. From 1960 on, epidemics of a then unknown feverish disease, called “epidemic
hemorrhagic fever” (EHF), were seen principally in the back alleys of Osaka and were characterized
by “marked but transient proteinuria”, a salient feature of all HFRS presentations [1,50]. In 32 EHF
cases, proteinuria peaked on day 6 post onset of symptoms (POS = sudden fever), and disappeared
almost completely by day 12 in severe, and by day 7 in mild AKI cases [50]. The severity of proteinuria
appeared to be a predictor for EHF clinical severity, a finding confirmed more than 50 years later in
70 cases of European PUUV. In this study, often massive proteinuria (1/3 in the nephrotic range) peaked
by day 5 POS and disappeared almost completely by day 11, whereas serum creatinine values peaked
on day 9 [51].
In May 1977, a link between EHF and Korean KHF, which had been rampant during the Korean
War, was established by demonstrating in a blinded test HTNV-like antibody in the sera of EHF cases
from Osaka, 7 to 17 years after acute EHF, but no antibody in the sera of healthy Japanese controls [52].
At least 120 residents in Osaka City were shown to have suffered from urban rat-transmitted EHF,
including two with a fatal outcome in the 1960s, followed by five laboratory rat-transmitted EHF cases
in the 1980s [53]. In a retrospective study, it appeared that already during the 1960s, 15/89 (16.8%)
brown rats captured in the Tokyo port area and 6/59 (10.2%) brown rats in a Tokyo suburb were
seropositive for this “HTNV-like” agent [54]. Two SEOV strains were isolated from these Tokyo urban
brown rats and called JTRN/82/14 and TR-352 VE8 [26].
Rat-transmitted EHF outbreaks in Japanese research laboratories were an extensive and recurrent
problem. In some animal rooms, e.g., at the Tohoku University in Sendai, 90% of 135 laboratory rats, and
in Wakayama Medical College, Wakayama city, 88% of 117 laboratory rats were reportedly infected by a
“HTNV-like” virus ([55], pp. 820–821). This infection was also reported in apparently healthy purchased
brown rats, although infection was denied by the rat-breeding companies, since rats appeared to be in
persistent good health. In the 1970s, at Tohoku University Hospital, Sendai, 14 scientists developed
serologically confirmed HFRS that was clinically mild, except in one case. Since this institution had
witnessed several recurrent outbreaks previously, the mysterious affection, originally called “Sendai
hemorrhagic fever” was re-named KHF, as patients had detectable “KHF-like antibody”. The antibody
was also present in three animal technicians who lacked a clinical HFRS-history, but who had worked
in the same room that housed the infected rats [56]. The clinical picture in infected humans differed,
however, from classical HFRS by a more pronounced hepatic, rather than a renal involvement, except
for a massive initial proteinuria, often over 3 gr/24 h [53].
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A prototype Japanese SEOV strain was isolated in 1983 from laboratory rats, called “Sapporo rat”
or SR-11 [21]. By the end of 1985, Japan had registered 129 laboratory-acquired HFRS cases from at least
17 animal rooms, which caused great concern in the Japanese press and TV [57]. In 1982, at the WHO
Collaborating Centre for Hantaviruses in Seoul, Korea, most of these rat and human samples were
confirmed as SEOV-infected, and HW Lee’s laboratory was officially designated to monitor laboratory
animal colonies of breeders in Japan ([55], pp. 826–827). Laboratory researchers reportedly contracted
HFRS more frequently than animal technicians or caretakers, although an animal caretaker died [57].
Another SEOV strain, called B-1, was isolated in 1983 from a laboratory rat tumor in an institution
where a HFRS case had occurred [58], in striking similarity with the later SEOV findings in the UK (see
below). On an island in Tokyo Bay, 99/355 (27.9%) of wild brown rats were found to be IFA-positive in
screening with the local Japanese SR-11, and a SEOV isolation called TR-352 was made [59]. Another
SEOV strain, KI-83-262, was isolated in 1983 from a wild brown rat captured on a dumping ground
in Hokkaido [60]. Rats were sampled from 1983–1992 in the same Tokyo Bay location and further
PRNT-confirmed SEOV isolations were made, including TQR-23, TQR-48 and TQR-50. This study
showed the multi-year persistence of SEOV infection in local urban brown rats in Tokyo, in contrast to
an originally putative recent local introduction [61]. This surprising finding was later confirmed in
several other follow-up studies in different countries, including the USA (see below).
Heavy proteinuria and hepatic or coagulation perturbations, rather than notable AKI, were
observed in 11 cases occurring in Nagoya City University Medical School, stressing again the peculiar
clinical presentation of this “HFRS” form [62]. As a further proof that SEOV infection was not only
present in laboratory rats, but also in wild commensal brown rats of the same Nagoya City, a SEOV
strain was isolated from a brown rat, captured in 1990 in a residential area and named NR-9 [63].
In 1994, comparison by RT-PCR of M genome nucleotide sequences found a homology of 93.4 to
98.1% in SEOV strains derived from laboratory rats (SR-11 and B-1), as well as from urban brown
rats captured in Japan (KI-83-262), Korea (Seoul 80-39) and China (R22, see below) [64]. This genetic
relative homology was confirmed later in other SEOV strains despite geographic and even worldwide
dispersion, thus hampering the determination of the exact geographic area of introduction or of human
SEOV infection, a challenge that persists even today [22].
In summary, the peculiar clinical presentation of a milder HFRS form, with marked but transient
proteinuria and heavy hepatic involvement, with wild and laboratory sources of infection, and with
diagnostic serological tools (IFA, later supplemented with PRNT) was described in Japanese literature
almost four decades ago. At that time however, disease names like KHF in Korea or the EHF in China
were used to designate SEOV-HFRS, even though these epidemic affections should more accurately be
restricted to illness caused by the Korean prototype HTNV [20]. Taking into account the magnitude of
the (SEOV-)HFRS problem in Japan, the first international and WHO-sponsored meeting on HFRS
took place in 1982, in Tokyo, Japan [14]. Although PRNT-confirmed SEOV infections were found
in some Japanese cases with hepatitis of unknown etiology [65], and despite Japan isolating several
distinctive SEOV strains from different rat sources, not a single new HFRS case has been reported
from Japan since 1984. This was in spite of SEOV-infected wild brown rats being continuously found
throughout Japan [66,67]. This situation was virtually the same worldwide for over three decades,
until the recent rediscovery of SEOV-HFRS in the West since 2012 [13]. This observation underlines
the diagnostic difficulties in detecting mild and “atypical” HFRS clinical disease in the Far East and
probably worldwide, including on the African continent [1,7,68].
SEOV in China
China was and still is by far the country most affected by HFRS epidemics, formerly called EHF.
EHF epidemics were recorded in China since the 1930s. During a noticeably long registry period,
1950–2014, the National Health and Family Planning Commission recorded a total of 1,625,002 EHF
cases with 46,968 deaths, or an overall case fatality rate of 2.89% [69]. The etiological relationship
between Korean KHF and Chinese EHF was first shown in 1980 [70], both supposedly caused by the
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Korean prototype HTNV. However, the co-occurrence of the milder “Rattus-type HFRS” was also
identified serologically in the early 1980s after the isolation of two Chinese SEOV strains, called R22
and K24, both from wild brown rats captured in the houses of Chinese EHF patients with frequent
rat exposure from the rural Henan province [20]. Rat-induced epidemics explained a predominant
but different “mild type of HFRS” in several regions in China, as was recognized already decades
earlier on clinical and epidemiological grounds alone [71]. Moreover, higher IFA titers from the
same mild HFRS cases were obtained in sera tested with the lung antigen from these “house rats”,
versus lower IFA titers obtained with the Korean prototype HTNV [71,72]. In contrast to severe HFRS
induced by the prototype HTNV, these SEOV-HFRS cases showed less hemorrhages, but increased
liver involvement [71,73]. Moreover, in the early 1980s, Song Gan et al. already remarked on an often
milder AKI, with a shorter clinical self-remitting course of approximately two weeks [72] and the
lower fatality rate of approximately 1% in SEOV-HFRS [69,72]. These observations were similar to
those made in Japan [50,53] and Korea [28], and heralded most of the comparable later findings in the
USA [2–4], North Vietnam [43], and France [7]. In fact, the same generally good prognosis, and rapid
self-remittance within two weeks without sequels, was later confirmed in most of the equally mild, but
PUUV-induced, European HFRS cases [51,68,74]. SEOV infections were considered in some Chinese
provinces to be more frequent than HTNV infections [75], especially in residential areas. Indeed,
clinically inapparent SEOV infection rates in “Rattus-type HFRS” regions could involve 8% up to 20% of
the local population—an interesting 1999 finding probably still applicable today to the current western
pet rat SEOV problem [73]. Finally, several HFRS outbreaks, mostly mild, but always involving people
working with infected laboratory rats, were reported from different Chinese laboratories from 1985
on [76–78]. Up to 2000, China counted at least nine different SEOV isolations from R. norvegicus (strain
L99, however, being from R. losea), and six SEOV isolations from humans [79] (See Figure 1, Asia).
This dual HTNV and SEOV infection pattern prompted mass vaccination campaigns in China, using
a combined inactivated vaccine that has now been used with success for decades [75,80]. In Taiwan
and in the early 1980s, 31/240 (13%) of humans were found to be IFA HTNV-positive, of which were
two HFRS cases [39]. Hitherto, SEOV remains the only confirmed hantaviral pathogen reported
from Taiwan.
Since milder SEOV cases can be easily missed clinically and may thus represent diagnostic
challenges [1,68], some authors suggested that SEOV might in fact be the most common hantaviral
pathogen in China [33]. As China accounts for over 90% of cases noted globally [75], SEOV might
consequently be the most important, but paradoxically also the most underestimated, hantaviral
pathogen worldwide.
3.1.3. SEOV in South-Asia
In Sri Lanka, 13/96 (13.5%) brown rats captured in 1987 in Colombo harbor was SEOV
antibody-positive by PRNT and a novel SEOV strain, called Sri Lanka R-1315, was isolated ([55],
pp. 1747–1748) and [81].
In 248 patients with leptospirosis-like illness in 1987, 14 (5.6%) appeared “HTNV
antibody-positive”, however, with equal PRNT titers for SEOV and for HTNV, suggesting a possible
third murid pathogen (THAIV?). Four cases were also ELISA IgM-positive and all had mild renal
involvement, one with lung symptoms, another with prominent hepatitis, and a third fatal case with
meningo-encephalitis [81]. Of note, 8/105 (7.6%) other leptospirosis-suspected patients from Kandy, Sri
Lanka, were likewise ELISA HTNV-seropositive, but showed clearly higher titers in PRNT for THAIV
than for SEOV, implying a pathogenic role for THAIV [82].
In May 1985 [39], 1/98 (1.1%) of human sera and a HFRS patient from India were “HTNV
antibody-positive”, whereas 15/204 (7.3%) of unknown hemorrhagic fever patients from the Indian
Andaman and Nicobar islands in 1990 reacted positive to the SEOV Sri Lanka strain R-1315, together
with 11/90 (12.2%) local wild brown rats ([55], pp. 820–821). A prospective 2006 study of South-Indian
patients, hospitalized in Cochin and Chennai with an acute leptospirosis-like illness with fever, AKI,
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“transaminitis”, and thrombocytopenia, found they were negative by micro-agglutination test and
Patoc ELISA for leptospirosis, and ELISA-negative for dengue fever. However, 7/60 (12%) patients
were positive in both the SEOV stripe immunoassay (SIA) and SEOV IgG ELISA. Six of these were also
positive in IgM SIA, confirming a recent infection. Of note, 3/60 (5%) of these other Indian cases in
contrast showed a clear PUUV-like SIA pattern, suggesting a cross-reaction with an as yet unknown
(arvicolid?) hantaviral pathogen, putatively present in the Indian subcontinent. Moreover, 2/3 of
these PUUV-like cases were fatal, despite combined acute hemodialysis and ventilation [83]. RT-PCR
performed later on all seropositive, but often thawed, samples found no hantaviral viremia [84].
In the Philippines, 51.5% of 167 Manila seaport rats, and 5% of 400 human sera were found
IFA HTNV-seropositive in 1983 [39]. In a later study of 461 asymptomatic study subjects, using a
high-density particle agglutination (HDPA) technique based on a HTNV 84/105 screening antigen, the
seroprevalence was about the same in males (6.1%), females (6.1%), and rural (7.6%), urban (5.6%),
or urban poor (5.1%) populations, suggesting possible domestic rat exposure [85]. A first report of
SEOV-HFRS and RT-PCR proven SEOV infection in urban rats followed from Bandung, Indonesia [86].
In a subsequent study in Indonesian patients with FUO, two cases of serologically and RT-PCR
proven SEOV infection were described, with severe “transaminitis”, however, without any evidence of
concomitant AKI [87].
3.2. SEOV in Oceania
In Australia, high antibody prevalence rates using HTNV-IFA screening were found in wild
brown rats captured between 1981 and 1983, with 2/16 (13%) positive in the Northern Territory, 2/12
(17%) in South Australia, 3/8 (38%) in Victoria, and 8/19 (42%) in Queensland [11]. However, no typical
HFRS cases were reported from Australia through 2005 despite documented HTNV-seropositive
rodents [88]. HTNV-like antibody-positive human and rat sera were found in Fiji between 1981 and
1985 [39]. A serological survey performed by IFA among 61 wild brown rats and 199 patients from
French Polynesia confirmed this evidence of “HTNV-like” infection in one rat and in two patients [89].
We found no data concerning New Zealand. In Hawaii, 8.8% of 1482 urban brown rats and 6.9% of 252
human sera appeared IFA HTNV antibody-positive [39].
While the various serological assays used differ from study to study and lacked specificity, it is
clear that these early observations from Asia and the Pacific regions suggest that hantaviruses, most
probably SEOV, were present in rodent populations, and likely caused human infections.
3.3. SEOV in Europe (Figure 2)
Although wild rats, serologically proven since the 1980s to be infected with a “HTNV-like”
patholological hantaviral agent in many European countries [10], scientific interest in their potential
impact on public health resurged only recently, reconstituting SEOV-induced HFRS as an “emerging
infection”(Figure 2).
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Figure 2. The map does not aspire to completeness and refers only to data given in the text. Except
for IR461, isolated in 1984 in Porton Down, Salisbury, UK [90], and for the Polle 18 SEOV strain,
isolated in 1988 in Germany (Lower Saxony) [91], all other European SEOV isolates are of more recent
dates (see text). The first (1978) western human SEOV infections, propagated by laboratory rats, were
clinically described in Belgium [92,93], whereas the earliest series of 16 clinically and serologically
proven SEOV-HFRS cases, after exposure to wild rats, was documented in County Down, Northern
Ireland, UK, 1994 [94]. For the 1983 and 1988 probable isolated SEOV-HFRS cases in Glasgow and
elsewhere in the UK, see the Supplementary Table S1 in the review by McElhinney et al. [95].
3.3.1. Russia
A large laboratory outbreak of HRFS-like disease in 1962 affected 83 technicians in Moscow and
led to suspicion that this then unknown febrile disease may have been spread by aerosols from infected
laboratory rats [96].
3.3.2. SEOV in Belgium and the Netherlands
In the late 1970s, three laboratory outbreaks of a new renal disease with fever, occasionally
necessitating acute dialysis, were all associated with handling and processing asymptomatically infected
laboratory rats. First described in a Belgian laboratory [92], they occurred almost simultaneously
in a Dutch laboratory involving four HFRS cases [97], and in a British laboratory [90,98]. Albino
brown rats, called Lou (from “Louvain”)/M/Wsl rats, and rat immunocytomas, were supplied upon
request from the Unit of Experimental Immunology, Catholic University of Louvain, Brussels, at a
time when hantavirus infection of laboratory rats was unknown and unsuspected in Europe. Once
diagnosed, these became the first cases of human illness due to a rat-borne “HTNV-like” virus and of
hantaviral infection in laboratory rats, documented outside East Asia [92]. Infectious aerosols may
have been generated from infected animals or tissue processing, resulting in the human infections
within the three affected laboratories. The origin of the virus was not identified, but infected rats
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were removed. Inspection of the three other Belgian institutions found no signs of infection among
either staff or rats. The specific diagnosis of SEOV infection was technically still impossible in 1983,
but the pathogen was found to be distinct from PUUV [92,99]. The virus was thought to have been
introduced between 1970 and 1974, and infected half of the 60 technicians working in the Brussels
laboratory. Similar HTNV-like IFA antibodies were retrospectively demonstrated in rats’ serum, inbred
during 1973–1982 [99]. Most of the infected technicians did not recall a HFRS-like illness; however,
three required hospitalization in 1978. The most severe case (peak serum creatinine 8.8 mg/dL) needed
three dialysis sessions and prompted a kidney biopsy. The patient presented very mild (0.2 g/L)
proteinuria on admission on day 3 POS, which peaked with the marked nephrotic range (19 g/L) on
day 6 POS, and disappeared completely by day 19 POS [93]. This characteristic fugacity in proteinuria
is typical for SEOV-HFRS [50], and probably for all HFRS forms as well [1,19,68]. It also indicated,
40 years ago, the necessity of repeated, or even daily, urine examinations for assessment of the full
magnitude of this frequent (but sometimes sole) form of renal involvement in HFRS [51]. Transient
microhematuria was also documented. The remarkably similar symptomatology of these three AKI
cases, all rapidly transient, led Belgian nephrologists to report the first (but still surprisingly valid)
Western purely clinical description of SEOV-nephropathy in 1979 [93], i.e., three years before the
publication of the causative pathogen itself [8]. This new scenario of HFRS originating from exposure
to infected laboratory rats was recently called a “second twist of SEOV exposure” involving unusual
interactions with rats, outside the realm of exposure to wild R. norvegicus, with a “third twist” being
the exposure to SEOV-infected pet rats [13].
A serological report of European human SEOV infection transmitted by laboratory rats followed
in 1991, involving 11 asymptomatic Dutch and Belgian laboratory technicians working with rats in
the 1980s [100]. In contrast, 14 non-laboratory but symptomatic “wild” HFRS cases, likewise in the
1980s, appeared to be PUUV-infected. Interestingly, two “wild” acute HFRS cases were only reactive to
Japanese SEOV strain SR-11, and not to PUUV, as confirmed in a then novel competition (blocking)
ELISA test. Consequently, these two cases, a Dutch farmer and a Belgian homeless person, both with
exposure to wild rats, were among the earliest serological demonstrations in the West of wild rat-borne
SEOV-HFRS [100]. Of note, of a total of 4750 rodents captured between 1986 and 1990 in Belgium,
the Netherlands and Germany, the brown rat was the second most IFA HTNV-seropositive species,
(2.1%), after the bank vole with 14.4% seropositivity [10]. Among 502 brown rats trapped from 2004
to 2006 in the Flanders region (Belgium), IgG against SEOV was found in 129 (27.1%). A molecular
investigation performed on six seropositive rats allowed the detection of one SEOV strain [101]. Of 16
wild brown rats trapped in 2013 in the Eastern province of Gerderland, three were found to be infected
by SEOV using serological (PRNT) and molecular assays [102]. Moreover, the first proven Dutch case
of SEOV-HFRS was recently documented [103].
3.3.3. SEOV in the UK
Between January and July 1977, four technicians of the Institute of Cancer Research (ICR), Sutton,
UK, became acutely ill with typical HFRS symptoms, some with acute lung injury. Three cases
required hospitalization and two needed acute dialysis due to anuria [98]. The Catholic University
of Louvain in Brussels that had a SEOV laboratory outbreak one year later (see above) had sent
apparently healthy but in fact SEOV-infected LOU rats, and their implanted immunocytomas to ICR
and other laboratories in Oxford, Sutton, and Bristol between 1974 and 1977. Other early reports of
similar laboratory outbreaks in Korea, Japan, and particularly in Belgium, signaled a breakthrough,
and the immunocytomas, which had been stored for eight to ten years at −70 ◦C in the Special
Pathogens Reference Laboratory, Porton Down, Wiltshire, were thawed. This led to the isolation of
five SEOV viruses in April 1984, cultured on Vero E6 cells, and labeled H95 to H99. They were later
renamed after the Belgian immunocytoma classification, bearing the French abbreviation “IR” (for
“immunocytome de rat”), as IR22 to IR1060 [90]. Some of these novel viruses were again renamed
“GB-B” (for “Great Britain”) and were used in IFA for diagnostic purposes [99,104,105]. A retrospective
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1984-5 investigation of ICR personnel revealed that 9/15 (60%) technicians working with Belgian rats
and/or rat immunocytomas had markedly higher IFA antibody levels against HTNV and the novel
UK hantavirus strains H96, H97, H98, and H99, as compared to a recently isolated Russian PUUV
strain, CG 18-20. SEOV-HFRS incurred by working on infected immunocytomas represented thus
another form of “second twist of SEOV exposure”, i.e., exposure with no direct contact with rats [13].
Belgian sera of rats with these implanted immunocytomas showed the same HTNV-like reaction
pattern, leading to the retrospective conclusion that the British 1977 HFRS outbreak was likely due to
a laboratory rat-transmitted hantavirus [90]. This was confirmed using monoclonal antibodies that
demonstrated that GB-B strains belonged to the “Rattus-type” hantaviruses [104]. A total of 19 years
later, isolate IR461 derived from an immunocytoma imported from Belgium to the Sutton ICR was
finally sequenced [106]. Since the ancestors of the Belgian LOU/M/Wsl rats had been housed in a
Japanese animal facility in Hokkaido, where SR-11 had been isolated, a close relationship between
IR461 and this Japanese laboratory rat strain was anticipated. However, a close and unexpected
clustering with two wild rat American SEOV strains, Baltimore rat virus and Belem (Brazil), was found.
These formed a unique clade grouping laboratory strain SR-11 with two wild rat American SEOV
strains, Girard Point virus and Tchoupitoulas (see below) [106]. The 1984 discovery of a SEOV strain in
the UK was the earliest isolation of a murid hantaviral pathogen in Europe and occurred at a time
when similar pioneer findings were being made in the Americas and in Africa, all during the early
1980s (see below).
A clinical series of 15 HFRS cases, mostly farmers hospitalized in the UK from 1989–1992 with
fever, AKI and thrombocytopenia (two with icterus), plus one asymptomatic control subject (also a
farmer) constituted the second piece of evidence in Europe of SEOV likely spread to humans by wild
rats, this time in Northern Ireland. Since Northern Ireland and Portugal are the sole regions in Europe
with the wild rat as the only known rodent reservoir of hantaviral pathogens, the almost exclusive IFA
and ELISA reactions to the Chinese (Henan province) wild rat R22 strain were deemed evidence of
acute SEOV infection [94]. This was later confirmed when rodents captured around patients’ farms in
County Down, Northern Ireland, yielded a high seroprevalence in 11/51 (21.6%) of wild brown rats,
when tested with the same SEOV R22 by IFA. This constituted a first warning of a new potential public
health problem caused by SEOV in the UK. [107]. Of interest, a Yorkshire famer was later proven
by IFA and SIA to have contracted SEOV-HFRS. Like his Northern Irish colleagues 20 years earlier,
leptospirosis was originally suspected, but not confirmed [108]. However, a brown rat on his farm
yielded in RT-PCR an amplicon having 97% nucleotide sequence similarity with the British laboratory
rat SEOV strain IR461, and resulted in a second British SEOV isolation, called Humber virus. For both
procedures, the same Chinese R22 strain, as had been used in 1993 and in Northern Ireland, was used
as the positive control [5].
Since 1983, a number of serologically confirmed HFRS cases have been reported in the UK
with probable or known associations to wild or pet rats, reviewed in McElhinney et al. A study of
epidemiologically related infections in pet rats and pet rat owners suggests a high prevalence of SEOV
within UK pet rat populations [95]. More recently, a survey of wild rats on farms in Northern England
has detected SEOV RNA in 19% (13/68, 95% CI 11 to 30) of rats and 12/13 sequences had 98% nucleotide
identity to the GB Humber strain of SEOV. Unlike in France, all UK SEOV sequences (laboratory, pet
and wild rat SEOV) to date have been exclusively associated with SEOV lineage 9 [109].
3.3.4. SEOV in Germany
The first SEOV isolation on the European continent was performed by J. Pilaski et al. from a wild
brown rat, caught in 1988 in Polle, Lower Saxony, Germany, and was called “Polle 18” [91]. We found
no record of this German hantaviral isolate being sequenced, but it was confirmed as being a novel
SEOV strain in the WHO Collaborating Centre for HFRS in Seoul, where in 1986, another SEOV-positive
rat from Germany was documented ([55], p.581). Recently, a SEOV infection was diagnosed in a
70-year-old German tourist returning from Sulawesi, Indonesia [22]. The initiating fever was situated
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before his departure from Indonesia, over 3 weeks before his eventual hospitalization for HFRS with
AKI back home in Hamburg, Germany. However, the rapid evolution of his laboratory parameters,
with, e.g., still rising blood levels of creatinine and leukocytes on day 2 and 3 of hospitalization,
suggested that he might have been infected more recently in Germany, after his return from Indonesia,
particularly in view of his still positive SEOV viremia, i.e., over 3 weeks after the presumed onset
of fever.
3.3.5. SEOV in Portugal, Greece, France and Sweden
The first (1993) HFRS case published in Portugal was a combination of mild non-oliguric AKI
(peak serum creatinine 4.73 mg/dL), but with heavy hepatic involvement, including pronounced
icterus (total bilirubin 23.42 mg/dL), both showing a spontaneous total recovery. This acute case was
negative in leptospiral serology but was serologically positive for SEOV [16,110]. SEOV remains the
only known hantaviral pathogen in that country [111]. The first IFA-SEOV-positive wild rat in Greece
was documented in 2000, albeit at a low titer (1/32) and with negative RT-PCR [112].
In France, in the 1980s, 19 of 70 (27%) Albino brown rats LOU/M/Wsl were found by IFA to
carry IgG against a HTNV-like virus. They were also bred in a Paris animal house for more than ten
years. Three animal caretakers were found seropositive, but none reported any HFRS disease [113].
In 1985, a HFRS case with icterus from the South West of France, exposed to wild rats, showed an IFA
seroconversion against HTNV, while the result was negative against PUUV, suggesting retrospectively a
SEOV infection [114]. A total of six HFRS cases, dating back to 1977–1996 was reported as serologically
suspected for a SEOV-infection [7,115] and one more in 2014 [116]. The first (2012) RT-PCR proven
SEOV-HFRS case in Europe was found in France in a pregnant woman, with hepatic and renal
complications that were clinically almost undistinguishable from pregnancy-induced autoimmune
liver disorders, complicated likewise by thrombocytopenia [117,118]. From 2014 to 2016, three
additional SEOV-HFRS cases followed in France, again with more hepatic than renal involvement.
One case had perfectly normal renal function parameters; however, clear thrombocytopenia was
initially present in all four proven SEOV infections [7].
The French SEOV-FHRS cases were associated with wild brown rats, pet brown rats and reptile
food brown rats, in which SEOV was also detected [7]. Previously, RT-PCR evidence indicated the
presence of SEOV in French reared brown rats, sampled in 2003, and in the wild from Lyon and
Orleans regions [119]. The presence of SEOV in wild brown rats from Lyon region was confirmed
later when 18/128 animals (14%) were found positive by RT-PCR [120]. Finally, a first French SEOV
isolation was recently obtained from a wild rat captured in Mantenay Montlin, Central France (Figure 2,
Europe) [121]. There is also the RT-PCR detection of SEOV in a pet rat from Sweden in 2013. The animal
was tested on the request of the owner. It was imported from the UK, but the origin of the SEOV
remains unclear [122].
Except for the more recently discovered Tula orthohantavirus (TULV), these results document the
early detection of at least two pathogenic hantaviruses in European rodents, likely to be SEOV and
PUUV, and demonstrate associated human infections from both laboratory and pet rats, and from rats
existing in the wild. The above findings suggest that these viruses are enzootic throughout many parts
of Europe, and remain a continuing but hitherto underestimated threat to human health.
3.4. SEOV in the Americas (Figure 3)
Human SEOV-induced HFRS cases were first and most reported from the Baltimore, MD, region
(See text and Table 1), although urban and wharf rats, proven in PRNT to be infected with SEOV, were
often demonstrated throughout the USA, and later likewise in South-America, wherever tested from
the early 1980s on (Figure 3).
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Figure 3. The map does not aspire to completeness and refers only to data given in the text. The first
SEOV isolation from a wharf rat captured in Philadelphia, USA, succeeded in 1984 [9], and was rapidly
followed by other isolations from wharf rats in different port cities in North and South America
(Belem, Brazil) (see text). The earliest (January 2, 1993) description of eight clinically and serologically
documented SEOV-HFRS cases, occurring after local floods in 1990, came from Recife, Brazil [123].
They also constituted the first proof of hantaviral pathogenicity for humans in the New World.
3.4.1. SEOV in North America
In the USA, 1982 was significant with the discovery of SEOV in the New World. A “HTNV-like
agent”, different from the European PUUV, was described in wharf rats in New Orleans, Philadelphia
and Houston [124,125]. In Baltimore, Maryland, up to 74% (32/43) of brown rats showed the HTNV-like
IFA reaction, as did three renal patients [126]. With these simultaneous observations, it was suggested
that a novel viral pathogen with renal tropism might have been introduced locally by international
shipping, a hypothesis later repeated in several other countries where HTNV-like seropositive brown
rats were discovered in port cities. However, rat infections were documented throughout inland
USA as well, a finding not supporting a recent introduction. As confirmed by the Center of Disease
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Control (CDC), infected brown rats seemed to be omnipresent in the USA: “Virtually everywhere we
looked-West coast, East coast, Cincinnati, New York City–we found (SEOV) infected rats” [127]. Of interest
to the recent American pet rat observations, several serosurveys in 1985 reported no evidence of
HTNV-like infection in brown rats in large-scale breeding colonies [128] or in cell-lines of brown rat
origin [129]. However, in 1985, a research technician working for five years in Frederick, Maryland, on
laboratory rodents (including brown rats) with virus-induced tumors, showed stable antibody titers to
prototype HTNV by PRNT but not against PUUV. This 31-year-old blood donor had no relevant travel
history, and did not recall any prior acute illness, suggesting that his infection was locally acquired
and asymptomatic [130].
Successful isolations of SEOV strains followed from 1984 on, all from wharf rats, respectively
captured in Philadelphia and Houston, called Girard Point virus (GPV) [9], in 1985 and in New Orleans
(Tchoupitoulas virus or TCHV) [128], and in 1987, in Baltimore (Baltimore rat virus, or BRV) [131].
GPV was found by PRNT as being clearly distinct from HTNV [9]. In 1988, prior SEOV infection
with local BRV was documented by PRNT in four life-long residents of Baltimore without a relevant
travel history; however, no clinical evidence of a typical HFRS episode was recorded, again suggesting
such rat-induced infections could occur asymptomatically [132]. Finally, on all continents, including
Africa, Australia, and Europe (Malmö, Sweden), infection was demonstrated in 243/910 (26.7%) of
peridomestic rats, confirmed by PRNT to be related to GPV, but not to HTNV [11]. Baltimore City,
however, remained the focus of American hantavirus research, with at least three ensuing studies
confirming the seroprevalence of approximately 50%, and up to 57.7%, SEOV-infected brown rats,
and a residential brown rat population density remaining apparently unchanged during estimations
in 1949, 1952 and 2004 [13,132–136]. A survey of the residents of Baltimore found that nearly 2/3
of respondents (64%) observed rats in streets and alleys, 6% saw rats inside residences, and 1.2%
had experienced a rodent bite in their lifetime [133]. Some of the Baltimore SEOV-seropositive study
subjects admitted that part of their daily home maintenance was to sweep rat feces from the paved
areas of their properties [13]. Nevertheless, the striking absence of noticeable HFRS in the USA, in
contrast to China, was recorded [13,19,137]. Following the extensive 1982 serosurvey of wharf rats in
seven American port cities [124], another novel SEOV was characterized in a New York City wharf
rat, and called NYC Baxter virus [138]. This virus was announced as probably recently introduced
into New York City, based on a “time to most recent common ancestor” (TMRCA) calculation, which
included the recently isolated (2012) British wild Humber strain [5]. However, an argument against a
recent SEOV introduction is that SEOV-infected brown rats were documented in New York City (NYC)
in 1985 [127,128], whereas predictions of the degree of rat infestation in several NYC boroughs, based
on the number of recorded rodent bites, did not show substantial changes between 1986 and 1994 [139].
In a recent overview, wild rats in the USA were described as being SEOV-positive in 13 states, from
Alaska to Mississippi and Hawaii. SEOV endemicity was confirmed by RT-PCR in New Orleans wharf
rats, apparently unabated over 30 years, i.e., since the 1985 isolation of TCHV virus from the same
city [140]. In Canada, 29/2063 (1.4%) human sera were found to be IFA HTNV-positive in the early
1980s [39], suggesting SEOV infection from wild (or domesticated?) rats, long before the local 2017
problem of SEOV-infected pet rats became (re)apparent.
3.4.2. SEOV in South America
GPV-positive brown rats were also found in Argentina and Brazil (6% in Recife and 65% in Belem),
resulting in the isolation of the first South-American hantaviral pathogen, Belem virus [141]. Two SEOV
PRNT-positive human sera were found in 1994 and in Brazil, one of which with a high antibody titer
in a resident of Sao Paulo, who had never travelled abroad, and with a presumptive diagnosis of
leptospirosis [142]. Four of 201 Brazilian leptospirosis-suspected samples from Belem were found in
1998 concomitantly IgM-positive for HTNV and for leptospirosis, suggesting a recent dual infection
with two different pathogens spread by wild rats. Two of these four sera were examined by PRNT
with one showing a low, and the other a strongly positive titer (1/320) for SEOV [143].
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Salvador is a port city in North-East Brazil, surrounded by rat-infested slum dwellings with a
very high leptospirosis endemicity. The continued presence of leptospira and SEOV was demonstrated
in commensal rats trapped during the rainy season of 2010, and complemented with unpublished
leptospira and SEOV prevalence information collected in 1998. SEOV was detected in 18% of wild
brown rats in both 1998 and 2010 (n = 78 in 1998; n = 73 in 2010), indicating that brown rats in Salvador
serve as permanent reservoir hosts for SEOV [144]. Previously, 13.2% of 379 asymptomatic Salvador
schoolchildren were found IFA-positive for a HTNV-like agent, but none for SNV, suggesting potential
rat exposure from a young age [18]. During a 1999 outbreak of urban leptospirosis after floods in
Salvador, a total of 326 AKI cases were detected, of which 39% were serologically confirmed, and
19% considered as probable leptospirosis cases [145]; however, the question remained as to which
other reno-tropic infectious pathogen could explain the remaining 42% unconfirmed cases [17]. Dual
concomitant human leptospirosis-hantavirus infections have been described in tropical regions endemic
for leptospirosis [146], as well as in Northern European non-endemic regions [147]. The earliest such
dual infection with AKI, in a non-tropical country, was reported from Glasgow, Scotland, in 1988 by G.
Kudesia et al. [95]. Despite these previous findings, no HFRS cases have been reported from Salvador
to our knowledge.
After the 1990 floods in the coastal Brazilian city of Recife, 8/156 (5.1%) hospitalized AKI cases
with thrombocytopenia were originally considered as leptospirosis, but were IFA-positive with R22, by
HDPA based on HTNV 84/105, and were IgM-positive by ELISA, suggesting recent SEOV infections.
These patients were negative for leptospira and PUUV serology. These eight Brazilian SEOV-HFRS
patients can thus be considered as being among the very first clinically and serologically proven cases
of human hantaviral illness in the New World [123].
In 1990, in Buenos Aires City, Argentina, 22.5% of 102 laboratory albino rats in three different
animal rooms were found HTNV-like–positive by IFA and PRNT, as were three technicians working
with rats in the same animal rooms [148]. In the same city, 18 years later, SEOV seroprevalence was
found in 11.9% of wild brown rats (n = 151), varying between 0 and 26.1% depending on the site.
The authors concluded that rat SEOV infection was geographically widespread in Buenos Aires City,
and had been enzootic there for at least 20 years. Nevertheless, no HFRS case had been noted from the
city during that period [149].
3.4.3. Conclusions For, and Table of American SEOV-HFRS Cases
Until recently, most reviews indicated that HFRS was relevant only for the Old World, but
absent from the New World. However, in addition to the eight Brazilian SEOV cases, two fatal SEOV
cases, one with lung involvement, were confirmed in Peru [150] and six clinically documented and
laboratory-confirmed SEOV cases, infected by wild rats, were found in the USA, in an observation
period stretching from 1994 to 2012 (Table 1) [12,151–153]. These USA SEOV-HFRS cases included one
lethal case (case 6 [153]), with both renal and fatal pulmonary involvement, confirming the ability
of SEOV to cause sometimes clinically severe, and even fatal, human infections in the New World.
Moreover, one out of these six American wild rat SEOV-HFRS cases also showed signs of secondary
hemophagocytic lymphohistiocytosis (HLH), a rare but often serious complication of mostly viral
infections, as noted before in Old World HFRS cases [154,155].
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Table 1. Characteristics of six reported (1994–2012) SEOV-HFRS cases in the USA, after reported or supposed exposure to wild rats.
Case no. Reference Location USA Peak S. Creat. Peak Proteinuria NadirPlatelets Transaminitis
Lab
Confirmation
ICU
Treatment Special Features
1 1994, Glass [12] Baltimore, MD 3 mg/dL 1700 mg/24hrs N.R. +++ PRNT N.R. Dyspnea and pleuraleffusions
2 1994, Glass [12] Baltimore, MD N.R. 954 mg/24hrs N.R. + PRNT N.R. Dyspnea
3 1994, Glass [12] Baltimore, MD 1.4 mg/dL 550 mg/24hrs N.R. + PRNT N.R. Pleural effusions andhemoptysis
4 2009, Woods [151] Baltimore, MD 12.3 mg/dL 600 mg/dL & 3+ 36,000/mm3 +++ RT-PCR 6 x Dialysis
Cough, high CK,
myoglobulinuria
5 2010, Nielsen [152] Milwaukee WI 1.53 mg/dL 2 + 26,000/mm3 +++ RT-PCR none
Hypoxia, pleural effusions,
ferritin 38,394 ng/mL. Liver
biopsy
6 2012, Roig [153] Brazoria, TX 6 mg/dL 2 + 114,000/mm3 ++ ELISA Ventilation Fatal ARDS
NR: not registered. PRNT: plaque reduction neutralization test. RT-PCR: reverse transcription-polymerase chain reaction. ARDS: acute respiratory distress syndrome. The very high level
of ferritin disclosed in case 5 [152] was strongly indicative of an underlying secondary hemophagocytic lymphohistiocytosis (HLH), but was not discussed by the authors. The liver biopsy
appeared non-contributive for diagnosis. The severity degree of accompanying, but rapidly self-remitting liver inflammation, was expressed as + to +++, according to the maximum
reported levels of hepatic transaminases.
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3.5. SEOV in Africa (Figure 4)
Urban rats collected between 1981 and 1983 in Port Said, Alexandria, Egypt, and Mombasa, Kenya
were IFA-positive for HTNV, and two rats from Egypt were confirmed PRNT-positive for GPV [11].
In 1982, 27% of 859 sera of urban rats captured in Cairo, Egypt, were found IFA-positive for HTNV, but
negative for PUUV, including 42.2% of rats captured in Cairo Governate ([55], pp. 297–298). The first
pathogenic hantavirus isolated from a local wild rodent in Africa was SEOV. Two different SEOV
strains from wharf rats captured in Cairo were isolated in 1983–1984 and called Egypt R/12915, and
Egypt R/13120 respectively, a finding in line with the demonstration of 19.9% (499/2,499) of wharf
rats being positive for HTNV-like antibodies, as were 1.3% (6/458) of an asymptomatic human cohort,
both from Cairo [39]. These data were later supplemented by H. Hoogstraal with 0.6% HTNV-like
prevalence in 154 human samples, and 23% prevalence in 1846 wild rat samples, both from Egypt [156].
A similar presence of HTNV-like antibodies was demonstrated in rat and human populations of
Djibouti [157]. Finally, the presence of a SEOV-like agent was found in a 2004 Egyptian study measuring
anti-hantavirus IgG, using ELISA with HTNV as screening antigen, in 350 patients with end-stage
renal failure (ESRF) and a group of 695 healthy controls. A prevalence of 1.4% was found among the
ESRF cases versus 1.0% in healthy controls, i.e., a statistically non-significant difference of p = 0.48.
According to a questionnaire, all antibody-positive study subjects (ESRF cases and controls) had been
exposed to wild rodents [158] (Figure 4).
Figure 4. The map does not aspire to completeness and refers only to data given in the text. The first and
only SEOV isolations in Africa to date were obtained from wharf rats in Cairo, Egypt, in 1983–1984 [39].
Despite strong evidence since the 1980s for the presence of a SEOV-like agent in humans and/or wild
rats in 17 different African countries, no full clinical and serological description of an autochthonous
SEOV-HFRS is available so far (see text).
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In Uganda in 1983, 15/355 (4.3%) serum samples of FUO patients were found to be
HTNV-like-positive, together with 3/64 (4.6%) feral rats [39] and ([55], pp. 1907–1908). In Sudan,
28/352 (7.9%) urban rats were equally found HTNV-like-positive [39]. In 1984, Gonzalez et al. reported
humans IFA-positive antibodies to a HTNV-like agent in four countries of Central and West Africa
(Central African Republic, Burkina Faso, Benin, and Gabon). Four of the highest IFA titers for HTNV
were, however, negative for the Korean prototype HTNV by PRNT, suggesting possible infection by
another closely related (murid?) African hantavirus [159]. Between 1985 and 1987, sera from 5070
randomly selected persons living in six central African countries (Cameroon, Central African Republic,
Chad, Congo, Equatorial Guinea and Gabon) were IFA-screened for antibodies to six different viral
hemorrhagic viruses (VHF). The highest sero-prevalence after Ebola VHF (12.4%) was for HTNV, with
6.15% [160]. Of note, this prevalence of 6.15% is noticeably higher than for most currently known
nationwide seroprevalence studies, even in countries long known as chronically endemic for hantavirus
infections. Finally, Gonzalez et al. reported the presence of IFA HTNV-like antibodies also in Rwanda
(0.4% of 280), Swaziland (3.4% of 202), Senegal (6.1% of 341) and Mauritania (2.4% of 82) [156].
Like in North America, South America, Japan, the UK, Germany, and Sri Lanka, where SEOV was
also the earliest isolated hantavirus, the rodent reservoir of prototype HTNV, A. agrarius coreae (the
Korean striped field mouse) is equally absent in Africa. This suggesting that these early serological
findings using HTNV-like antigens may likely be ascribed to cross-reactions with SEOV, or a very
closely related murid hantavirus [156].
More recently, Sangassou virus (SANGV) has been isolated and functionally characterized in cell
culture as a novel second murid hantavirus species in Africa [161], Specific neutralizing antibodies
against SANGV virus, were demonstrated in two FUO patients and in two other samples from Guinea,
West-Africa [161]. Finally, an Abidjan, Côte d’Ivoire, patient with AKI was found IgM-positive to
Bowé virus, another newly described hantavirus carried by an insectivore (not a rodent), Doucet’s
musk shrew, but remained negative by RT-PCR [162]. Serological studies detected human hantavirus
antibodies in West Africa, and a seroprevalence of 1.0% in the human population of the South African
Cape Region (n = 1442). However, no clear-cut human pathogenicity was found caused by SANGV,
nor by other novel hantaviruses, characterized in shrews and bats [163]. Clearly our understanding
of the hantaviruses in Africa remains incomplete; however, human HTNV-like infections, previously
documented in 17 different African countries, may suggest that SEOV is a substantial cause of hitherto
unrecognized African HFRS, or even HCPS cases, given the omnipresence of wild rats, particularly in
urban settings.
4. Current Situation
In 2012, a Welsh pet agouti rat owner developed a severe MOF, with a combination of AKI,
progressive lung and liver involvement, coagulation disorders and lactic acidosis, initially ascribed to
overwhelming sepsis, needing 38 days of ventilatory support and 21 days of renal replacement therapy,
but ending in full pulmonary and renal recovery. Ultimately, SEOV infection was confirmed by IFA,
but SEOV viremia was not detected [6]. Rat-borne SEOV was traced back to a pet rat breeding site in
Cherwell, England, where two owners were apparently also infected in 2011, one asymptomatically,
the other requiring hospitalization for AKI with thrombocytopenia, secondary to a then unidentified
viral illness [5]. These cases launched an investigation in the UK into the extent of SEOV infection
among pet or domestically bred rats and their owners or breeders. IFA SEOV-IgG seropositivity in
27/79 (34.1%) was found among breeders versus much lower IgG prevalences in all other control
groups (farmers and other professions with rat-exposure), encompassing 844 human serum samples.
No clinical complications were found [164]. By contrast, the extended Cherwell rat study revealed
SEOV RNA presence in different organs of 17/21 (81%) rats, and anti-SEOV antibodies in 100% (20/20)
in blood tested by PRNT and ELISA [95]. These findings were much higher than the preliminary RNA
RT-PCR screening of Cherwell rat blood alone, which found 7/21 (33%) positivity [5]. Partial L segment
sequencing of SEOV viruses from Cherwell and Cheltenham (another English pet rat SEOV strain)
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clustered closely together with two wild rat strains, American NYC Baxter and British Humber, and
with IR 461, a lab rat strain [95].
In France, the link between infecting rats and human HFRS cases was demonstrated by highly
similar nucleotide sequences derived from both patient and rats [7]. After a SEOV-HFRS outbreak
in 2006 among eight students of the Shenyang Pharmaceutical University, Liaoning Province, China,
phylogenetic analysis revealed that the same SEOV strain had affected both patients, laboratory
rats, and wild rats, the latter captured on the grounds of the concerned pharmaceutical building.
This confirmed for the first time the triple scenario that SEOV-infected wild rats can infect laboratory
rats, which in turn can infect humans [78].
This paucity of SEOV cases in the West and in Africa contrasts with the long-standing recognition
of cases in the East, particularly in China, even since the early 1980s. The prevalence of SEOV-infected
rats is similar in many parts of Asia to that found in Europe, the Americas and Africa, and appears to
have been fundamentally unchanged over decades.
Human SEOV-HFRS has until recently (2012) been underestimated in the West [1,16–19,68,165].
The reasons for this are not clear, but differences in the degree of exposure and the availability of
diagnostic testing probably play a role: in China, virtually all HFRS cases are serologically screened
with HTNV, which cross-reacts with SEOV. In contrast, in Europe, serologic screening relies primarily
on PUUV antigens [7,19], while in the Americas, SNV and/or ANDV antigens are most frequently
used, and HTNV and/or SEOV antigens are not [16,18,22,94], thus probably missing some isolated
SEOV cases. In parts of Europe, Dobrava-Belgrade orthohantavirus (DOBV), another murid pathogen
isolated in 1988, can cause important cross-reactions with SEOV in IFA and ELISA serology [22].
Serologic analysis using two commercial European immunoblots was misleading in the first reported
SEOV-HFRS case in Germany. The commercial Hantavirus Profile 1 Immunoblot (Euroimmun, Lübeck,
Germany) lacked a SEOV antigen, and the recomLine HantaPlus IgG and IgM blot assays (Mikrogen,
Martinsried, Germany) showed reactivity for the three murid pathogens DOBV, HTNV, and SEOV, but
yielded the weakest result for SEOV nucleocapsid protein. The final diagnosis was only possible after
RT-PCR examination on the earliest available acute serum sample after hospitalization in Hamburg,
Germany [22]. In this aspect, it is useful to remember that if the IgG IFA screening of the first British
series of North-Irish farmers with acute hantavirus-induced AKI had been performed only with the
then classical antigens PUUV and HTNV, but without the Chinese SEOV antigen R22, 13/15 (86.7%) of
the cases would have been missed in 1994, which is unacceptable [94].
In contrast, Canadian and British military personnel, both originally suspected of severe
SEOV-induced MOF during the Bosnian War, were later shown to be in fact DOBV infections [166].
Another possible explanation for the striking East–West difference in SEOV-HFRS incidence is that
American SEOV strains might be less virulent than their Asian counterparts [133]; however, SEOV
phylogenetic trees show American SEOV strains clustering closely with Asian strains. In a recent
South-Korean study applying next generation sequencing, multiple strains of SEOV of worldwide
origin were examined. A phylogenetic tree of sequences of small RNA segments revealed a grouping
of strains from the UK and the USA, clustering together with another group containing American
Tchoupitoulas, Japanese Sapporo and Korean strains, including prototype SEOV 80-39. These findings
are not suggestive of a fundamental difference between infecting wild rat strains (e.g., Humber and
NYC Baxter), lab rat strains (e.g., Sapporo and all the British IR strains), or pet rat strains (e.g.,
Cherwell). [167]. This may be to be expected, since all are carried by the same rat species, R. norvegicus.
Nor was the phylogenetic tree suggestive of a recent introduction of all these rat strains in the respective
countries, since IR 461 was isolated in 1984, and stemming from Belgian laboratory rats, that were
presumably infected with the same SEOV already in the 1970s [95]. In summary, the paucity of
recognized SEOV cases outside Asia may reflect insufficient medical awareness of the “atypical” and
often very mild aspects in SEOV-HFRS cases, implying even HFRS cases with preserved normal kidney
function throughout [1,87]. JE Childs, familiar with the wild rat problem in Baltimore, MD, describes
the current situation as follows: “physician awareness of this rare disease is negligible, and public
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health surveillance non-existent. Acute illness caused by SEOV, does not have a unique presentation,
and signs and symptoms are consistent with a wide range of diseases” [13].
The current problem of SEOV infection in pet rats likely arose from SEOV-infected wild brown
rats, visiting commercial or domestic ratteries, rather than stemming from laboratory rat colonies [106],
although the latter scenario was also proven by RT-PCR in China [78]. Laboratory rats today are
generally free of SEOV infection due to strict adherence to the total eradication of infected rats [57,92],
followed by a worldwide policy of continuous SEOV screening, imposed traceability of rat batches,
and/or other preventive techniques [7,99]. These policies are probably not in place in small, private
ratteries [7], and in view of the sometimes high SEOV prevalence in wild brown rats, it is not surprising
that infected domesticated rat colonies became established, and human infections followed. The lesson
learned from recent British and American pet rat investigations is that pet rat owners and breeders
are at increased risk of SEOV infection due to frequent close contact with their companion animals,
but when present, acute disease is rarely severe or life threatening. This is based on the repeated
observation that SEOV infection usually resulted in very mild illness [3,103], without mention of
renal involvement [2,164], but with the possible exception of missed initial proteinuria [1,50,53]. Since
proteinuria and even all degrees of concomitant AKI are almost always spontaneously self-remitting
within 2–3 weeks in most cases of HFRS [6,22,68,74,103,151,152], the initial fear that rat-borne SEOV
represents a newly discovered public health problem might not be justified. A heightened clinical
acumen for the mild and/or atypical presentation of SEOV-HFRS is, however, clearly needed in the West.
5. Conclusions
Since the 1976 original discovery of HTNV, a large body of evidence has accumulated over
the ensuing four decades regarding the global distribution and clinical characteristics of hantaviral
infections in both humans and small mammal hosts.
With increasingly sophisticated technology and enhanced clinical awareness, many specific
hantaviruses are now recognized; however, SEOV remains the most widely distributed hantavirus.
SEOV is maintained in nature among chronically infected brown rats that are found in virtually
every corner of the world, living in close association with humans, yet the incidence of SEOV human
infections varies widely between Asia, where its pathogenic potential is well recognized, and the
remainder of the world, where very few human cases have been documented. The even greater
exposure to SEOV-infected pet rats, potentially likewise on a global scale, might significantly change
this situation.
SEOV infections should be considered in patients presenting with a febrile illness associated with
transient thrombocytopenia and proteinuria, accompanied by rapidly resolving hepatitis, especially if
a history of possible exposure to brown rats is elicited.
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